Results 221 to 230 of about 235,344 (293)

Safety pharmacology of acute mescaline administration in healthy participants

British Journal of Clinical Pharmacology, EarlyView.
Aims Psychedelics, including mescaline, may serve as novel treatments for depression and anxiety. However, data is scarce on the safety of mescaline. Methods The present pooled analysis included two double‐blind, randomized, placebo‐controlled studies with a total of 48 participants and 96 mescaline administrations. Single oral‐dose administrations (n =
Aaron Klaiber, Mélusine Humbert‐Droz, Laura Ley, Yasmin Schmid, Matthias E. Liechti   +4 more
wiley   +1 more source

Irritable bowel syndrome management: current insights. [PDF]

Singapore Med J
Ang D.
europepmc   +1 more source

Role of the Amygdala in the Complex Relationship Between Sleep and Anxiety. [PDF]

Int J Mol Sci
Grzybowski F, Kaczmarski P, Strzelecki D, Wysokiński A, Białasiewicz P, Gabryelska A.   +5 more
europepmc   +1 more source

The working lives of neuronal 5-HT_2A receptors from the outside in. [PDF]

RSC Chem Biol
Jabar A, Pinto M, Hébert TE.
europepmc   +1 more source

In vitro profiling of Trypanosoma cruzi inhibitors identified from High throughput Screening and application to parasite painting. [PDF]

Int J Parasitol Drugs Drug Resist
Baek KH, Lee H, Byun S, Genilloud O, Ioset JR, Shum D, No JH.   +6 more
europepmc   +1 more source

The Serotonin 2B (5-HT2B) Receptor: A Narrative Review of Preclinical and Clinical Evidence on the Safety Considerations and Therapeutic Potential for the Treatment of Depression. [PDF]

Clin Pharmacol Ther
Le GH, Wong S, Johnson DE, Orsini DK, Zheng YJ, Teopiz KM, Dri CE, Rosenblat JD, McIntyre RS.   +8 more
europepmc   +1 more source

The serotonin axis in cancer: metabolism, epigenetics, and immune regulation. [PDF]

Mol Cancer
Zhu J, Bai J, An L, Zhang C.
europepmc   +1 more source